WST

West Pharmaceutical Services
D

WST

Arincen83/100B

West Pharmaceutical Services cash flow statement 1989–2026

West Pharmaceutical Services's free cash flow over the last twelve months was 453.40M USD: operating cash flow of 654.50M USD less 201.10M USD of capital spending. That is 13.3% of its revenue and 6.31 a share.

Operating cash flow Free cash flow

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
30 Sept 2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Net income
638.90M493.70M492.70M593.40M585.90M661.80M346.20M241.70M206.90M150.70M143.60M
Depreciation and amortization
183.70M171.40M155.40M137.30M120.60M122.30M109.10M103.40M104.40M96.70M90.70M
Stock-based compensation
28.50M23.80M18.70M23.30M23.70M37.50M34.00M24.40M15.10M16.10M19.50M
Change in working capital
44.50M79.80M2.90M-20.40M-15.00M-193.80M-10.30M-14.40M-28.30M-41.40M-58.70M
Change in receivables
—6.90M-58.80M4.00M-35.60M-123.50M-46.60M-33.30M-43.80M-39.70M-23.30M
Change in inventory
—-62.80M42.00M-13.50M-49.80M-86.50M-73.70M-18.60M-7.00M-3.60M-21.20M
Change in payables
—17.90M2.90M4.40M-2.80M16.80M36.60M25.30M400.00K12.60M6.10M
Change in other working capital
100.40M117.80M16.80M-15.30M73.20M-600.00K73.40M12.20M22.10M-10.70M-20.30M
Other non-cash items
-241.10M-200.00K-16.30M5.40M36.10M-900.00K-700.00K-3.20M-10.40M-500.00K2.80M
Operating cash flow
654.50M754.80M653.40M776.50M724.00M584.00M472.50M367.20M288.60M263.30M219.40M
Operating cash flow growth
-5.66%+15.52%-15.85%+7.25%+23.97%+23.60%+28.68%+27.23%+9.61%+20.01%+3.30%
Capital expenditure
-201.10M-285.90M-377.00M-362.00M-284.60M-253.40M-174.40M-126.40M-104.70M-130.80M-170.20M
Acquisitions
—0.000.000.000.00-2.20M0.00-104.00M0.00-6.00M0.00
Purchases of investments
—0.000.000.000.000.000.00-85.10M0.000.00-8.40M
Sales and maturities of investments
—0.000.000.000.000.000.0085.10M0.000.000.00
Other investing
—0.00-1.70M-6.70M-3.60M2.50M-5.10M2.40M3.90M3.20M2.80M
Investing cash flow
-83.10M-285.90M-378.70M-368.70M-288.20M-253.10M-179.50M-228.00M-100.80M-133.60M-175.80M
Debt issued (repaid)
-1.50M-1.10M-27.60M-2.30M-44.30M-2.20M-2.30M62.10M-100.00K-34.90M-69.80M
Shares issued
—18.20M0.000.000.000.000.000.000.000.000.00
Share buybacks
-231.20M-134.00M-566.60M-451.20M-222.20M-151.90M-121.40M-85.30M-70.80M-74.40M-55.90M
Dividends paid
-62.80M-61.20M-59.10M-57.00M-54.10M-51.10M-48.10M-45.10M-42.10M-39.10M-35.80M
Other financing
-438.00M-7.00M30.70M50.90M27.00M37.10M34.70M31.50M32.30M39.40M47.60M
Financing cash flow
-727.00M-185.10M-622.60M-459.60M-293.60M-168.10M-137.10M-36.80M-80.70M-109.00M-113.90M
Net change in cash
-164.40M306.70M-369.30M-40.40M131.70M147.10M176.40M101.70M101.50M32.90M-71.60M
Free cash flow
453.40M468.90M276.40M414.50M439.40M330.60M298.10M240.80M183.90M132.50M49.20M
Free cash flow growth
+19.60%+69.65%-33.32%-5.67%+32.91%+10.90%+23.80%+30.94%+38.79%+169.31%-39.11%
Free cash flow margin
13.35%15.26%9.56%14.05%15.23%11.68%13.89%13.06%10.70%8.28%3.26%
Free cash flow per share
6.316.453.755.505.804.333.933.192.441.750.66
Free cash flow per share growth
+21.68%+71.98%-31.87%-5.04%+33.79%+10.18%+23.14%+30.94%+39.53%+166.47%-40.08%
Interest paid
——500.00K6.00M6.60M8.00M8.10M8.60M8.40M8.00M8.60M
Income taxes paid
—0.0071.40M90.80M109.70M171.80M48.40M47.50M42.00M31.00M48.10M

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Common questions about West Pharmaceutical Services's cash flow

Source: Financial Modeling Prep